化学名称: (1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-((1R,2S)-2-(3,4-difluorophenyl)cyclopropoxy)ethoxy)cyclopentane-1,2-diol
微笑: FC1=C(F)C=CC([C@H]2[C@H](OCCO[C@@H]3[C@@H](O)[C@@H](O)[C@H](N4N=NC5=C4N=C(SCCC)N=C5N)C3)C2)=C1
印地语: InChI=1S/C23H26F2N6O5S/c1-2-7-37-23-27-21(26-16-15(20(16)35)10-3-4-11(24)12(25)8-10)17-22(28-23)31(30-29-17)13-9-14(36-6-5-32)19(34)18(13)33/h3-4,8,13-16,18-19,32-34H,2,5-7,9H2,1H3,(H,26,27,28)/t13-,14+,15?,16?,18+,19-/m1/s1
Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.
From World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.
Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav
From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724
Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara
From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42